1. Introduction {#sec0005}
===============

Cyprus is a European Union member island state situated in the eastern Mediterranean basin (35°10′N and 33°22′E) with a temperate climate. Several tick-borne pathogens are endemic in domestic ruminants (goats, sheep and cattle) ([@bib0030], [@bib0025], [@bib0120]), wild animals (mouflon, fox and hare) ([@bib0030], [@bib0065], [@bib0125]) and migratory bird populations of the island ([@bib0060]). *Rhipicephalus sanguineus* sensu lato, the main vector for several canine tick-borne pathogens (CTBP), is the most common tick species found in dogs in Cyprus ([@bib0030], [@bib0040], [@bib0070]). The only vector-borne disease (VBD) previously reported in dogs in Cyprus is leishmaniosis ([@bib0085]). Up to now, no studies have yet reported the presence of CTBP in Cypriot dogs.

This report describes, for the first time, the molecular detection of *Ehrlichia canis*, *Anaplasma platys*, *Hepatozoon canis*, *Babesia vogeli* and *Mycoplasma haemocanis* in three naturally-infected dogs from Cyprus with clinical signs compatible with VBD.

2. Material and methods {#sec0010}
=======================

Three dogs from Cyprus, designated as Cases 1, 2 and 3, with no overseas travel history and with clinical signs compatible with VBD, were admitted to Cyvets Veterinary Center, at Paphos, in 2013 and included in this study.

At clinical presentation, as part of diagnostic procedures, blood samples were collected into EDTA and heparin tubes and analysed by an automated haematology impedance analyzer (Vet ABC, Scil, Viernheim, Germany) and by a VetScan VS2 chemistry analyzer (Abaxis, USA), respectively. Blood smears prepared on glass slides at the time of blood collection were air-dried and stained with Giemsa (Merck, Darmstadt, Germany) and examined by light microscopy. Additionally, plasma samples were evaluated for the presence of antibodies against *E. canis*/*E. ewingii*, *Borrelia burgdorferi* sensu lato, *A. platys/Anaplasma phagocytophilum* and the presence of *Dirofilaria immitis* antigen using the SNAP 4Dx^®^ Plus test (IDEXX Laboratories, Westbrook, Maine, USA). Urine samples were collected via cystocentesis and analysed using the Multistix 10SG urine reagent strips (Siemens AG, Munich, Germany).

Following diagnostic testing and with written owner consent, surplus stored EDTA-blood was used retrospectively for this study. DNA was extracted from 100 mL of EDTA-blood using a commercial kit (NucleoSpin^®^ Blood, Machery-Nagel, Germany) according to the manufacturer\'s instructions. Real-time quantitative polymerase chain reaction (qPCR) assays were used to investigate for the presence of haemotropic mycoplasmas (*M. haemocanis* and '*Candidatus* Mycoplasma haematoparvum'), *B. burgdorferi* sensu lato and *Bartonella henselae,* conventional PCRs were used to evaluate for *Ehrlichia/Anaplasma* spp., *Hepatozoon* spp., *Babesia* spp. and *Leishmania* spp. infection, and a nested *E. canis*-specific PCR assay was also performed ([Table 1](#tbl0005){ref-type="table"}) ([@bib0015], [@bib0035], [@bib0045], [@bib0050], [@bib0055], [@bib0080], [@bib0110], [@bib0115], [@bib0130]). To confirm the presence of amplifiable DNA and absence of PCR inhibitors, all qPCR reactions were duplexed with an internal control for glyceraldehyde-3-phosphate dehydrogenase. For each PCR run, positive controls using DNA from known infected dogs and negative controls using water were included.

After conventional PCR amplification, the amplicons from any positive *Ehrlichia/Anaplasma* spp., *Hepatozoon* spp., *Babesia* spp. and *E. canis* PCR assays were purified (ExoSAP-IT, Affymetrix, USB, Cleveland, Ohio, USA) and the DNA sequenced on both strands using the respective forward and reverse PCR primers. For each DNA amplicon forward and reverse sequences were assembled, and a consensus sequence constructed, using ClustalW in Bioedit. DNA sequences were deposited in GenBank and checked for identity against previously deposited sequences, using NCBI BLAST ([@bib0005]). Sequences obtained in this study were aligned to selected sequences of the respective genes, from the same and related species of organism, previously deposited in GenBank using ClustalW. Phylogenetic trees were constructed using the maximum likelihood program, corrected for nucleotide substitutions by the Kimura-2 parameter model, in MEGA version 6 ([@bib0145]). The data set was resampled 1000 times to generate bootstrap percentages.

3. Case reports {#sec0015}
===============

3.1. Case 1 {#sec0020}
-----------

A 1.5-year-old, entire male, mixed-breed dog presented with a 6-day history of depression and anorexia. The dog lived outdoors in rural Paphos-area. Physical examination revealed pale mucous membranes with widespread petechial haemorrhages. Body condition score was 4/9. Haematology showed a mild normochromic normocytic anaemia (haematocrit \[Hct\] 34.5%; reference interval \[RI\] 44--57%), monocytosis (1.4 × 10^9^/L; RI 0.0--0.5 × 10^9^/L), lymphocytosis (4.0 × 10^9^/L; RI 1.0--3.6 × 10^9^/L) and a moderate thrombocytopenia (65 × 10^9^/L; RI 200--460 × 10^9^/L), while no abnormalities were detected on biochemistry and urine analysis. Giemsa stained peripheral blood smear examination revealed the presence of gamonts of *Hepatozoon* spp. intracellularly in 0.2% of neutrophils. Seropositivity for *E. canis/E. ewingii* was also detected. Based on the physical examination, haematological abnormalities and serological results, a diagnosis of *Hepatozoon* spp. infection was established, with presumptive co-infection with *Ehrlichia* spp. Treatment with doxycycline (Ronaxan, Merial, Lyon, France; 5 mg/kg orally twice daily for 28 days) was given. Abnormalities were not detected on repeat physical examinations, haematological analysis and blood smear examination on days 28 and 134 following treatment initiation. Subsequent PCR on pre-treatment stored blood samples and sequencing analysis confirmed both *E. canis* and *H. canis* infection and revealed concurrent infection with *B. vogeli* and *M. haemocanis*.

3.2. Case 2 {#sec0025}
-----------

A 7-year-old, entire female, mixed-breed dog presented with a 4-month history of lethargy, weakness, anorexia and weight loss. The dog lived outdoors in rural Paphos-area. Physical examination showed peripheral lymphadenomegaly, a body condition score of 2/9, pale mucous membranes, epistaxis and bilateral blepharitis, conjunctivitis with mucopurulent ocular discharge and anterior uveitis. Haematology revealed a moderate normochromic and normocytic anaemia (Hct 19.0%; RI 44--57%), leucopenia (4.2 × 10^9^/L; RI 6.0--12.0 × 10^9^/L), lymphopenia (0.6 × 10^9^/L; RI 1.0--3.6 × 10^9^/L) and thrombocytopenia (118 × 10^9^/L; RI 200--460 × 10^9^/L). Biochemical abnormalities included hyperproteinaemia (94.5 g/L; RI 54--82 g/L), hyperglobulinaemia (74 g/L; RI 23--52 g/L) and hypoalbuminaemia (20 g/ L; RI 25--44 g/L). No abnormalities were detected on urine analysis. Blood smear examination revealed 0.8% of neutrophils to be parasitized by gamonts of *Hepatozoon* spp. Serology was positive for *E. canis/E. ewingii*. *Leishmania* amastigotes were noted in macrophages and extracellularly on fine needle aspiration cytology (Giemsa stained) of the right submandibular lymph node. A diagnosis of clinical leishmaniosis with concurrent *Hepatozoon* spp. infection and presumptive co-infection with *Ehrlichia* spp. was made. Further investigation and treatment for leishmaniosis was discussed, however, the owners elected euthanasia and declined necropsy. Subsequent PCR on pre-treatment stored blood samples confirmed *Leishmania* spp. infection while PCR and sequencing analysis revealed the presence of *E*. *canis* and *H*. *canis*.

3.3. Case 3 {#sec0030}
-----------

A 1-year-old, neutered female, mixed-breed dog presented with a 2-day history of decreased appetite and right hindlimb lameness. The dog lived partially outdoors in urban Paphos. Clinical examination revealed right stifle soft tissue swelling and pyrexia (39.3 °C). Haematology showed a moderate normochromic and normocytic anaemia (Hct 18.9%; RI 44--57%) and thrombocytopenia (64 × 10^9^/L; RI 200--460 × 10^9^/L). Blood smear examination revealed *A. platys* morulae within most of the platelets. No abnormalities were detected on biochemistry and urine analysis. Cytological examination of the synovial fluid (Giemsa stained) from the right stifle identified a neutrophilic arthritis. No other joints were sampled. Serology, using the SNAP 4Dx^®^ test, was unremarkable. An initial diagnosis of thrombocytotropic anaplasmosis was made and the dog was treated with doxycycline (Ronaxan, Merial, Lyon, France; 5 mg/kg orally twice daily for 28 days). On days 28 and 134 following treatment, the dog was described as being healthy by the owner via telephone communication, but repeat examination was declined. Subsequent PCR on stored pre-treatment blood samples and sequencing analysis confirmed *A. platys* infection.

4. Results {#sec0035}
==========

4.1. Sequence and phylogenetic analysis {#sec0040}
---------------------------------------

The sequencing results of products derived from positive *Ehrlichia/Anaplasma* spp., *Hepatozoon* spp., *Babesia* spp. and *E. canis* PCR assays, together with the lengths of the sequence data obtained, are shown in [Table 1](#tbl0005){ref-type="table"}, alongside the GenBank accession numbers for the generated sequences.

On phylogenetic analysis, all of the *H*. *canis* sequences compared clustered together, including those from Cases 1 and 2, in a single clade, separate from *H. felis* and *H. ursi* ([Fig. 1](#fig0005){ref-type="fig"}A). All *B. vogeli* sequences compared, including that from Case 1, also clustered together in a single clade, distinct to other *Babesia* and *Theileria* spp. ([Fig. 1](#fig0005){ref-type="fig"}B). All *E. canis* sequences compared, including those from Cases 1 and 2, clustered together in a single clade supported, distinct to other *Ehrlichia* and *Anaplasma* spp. ([Fig. 1](#fig0005){ref-type="fig"}C). Most of the *A. platys* sequences compared, including that from Case 3, clustered closely together in a single clade ([Fig. 1](#fig0005){ref-type="fig"}D), although one *A. platys* sequence from China branched separately, albeit with a relatively low bootstrap value.

5. Discussion {#sec0045}
=============

Canine tick-borne pathogens such as *E. canis*, *H. canis*, *B. vogeli* and *M. haemocanis* have been documented in several European countries especially in the Mediterranean region where the temperate climate sustains the presence and activity of *R. sanguineus* sensu lato which is considered the major vector for the transmission of these pathogens ([@bib0010], [@bib0105], [@bib0135], [@bib0140]). Two previous studies have described the canine tick flora found on dogs in Cyprus, with *R. sanguineus* sensu lato comprising 87.5-89.4% of ticks collected ([@bib0030], [@bib0070]). No previous studies have investigated CTBP in Cypriot dogs.

Case 1 was diagnosed with likely acute monocytic ehrlichiosis, and even though it was co-infected with three additional CTBP (*H. canis*, *B. vogeli* and *M. haemocanis*) the clinical and haematological outcome did not appear to be worsened. Co-infection has previously been demonstrated in Greek dogs; one study demonstrated that 65% of dogs in Greece, with naturally-occurring monocytic ehrlichiosis, were also seropositive to *H. canis* ([@bib0095]). In the same study, the prevalence of *H. canis* parasitaemia and the number of circulating gamonts were low, and *H. canis* infection did not appear to exacerbate the clinical manifestations or the haematological abnormalities of monocytic ehrlichiosis. In Case 1, there was a low degree of *H. canis* parasitaemia (\<5%), which might suggest limited involvement in the clinical signs of the dog ([@bib0010]). The fact that there was no cytological evidence of *H. canis* parasitaemia after follow-up cytological review of the peripheral blood smear, coupled with the complete clinical and haematological recovery following doxycycline treatment, suggests that this infection was not a critical determinant in the clinical and clinicopathologic outcome. The clinical relevance of the *B. vogeli* and *M. haemocanis* infections in Case 1 is uncertain, as both pathogens tend to affect splenectomized dogs more severely, and their clinical and haematological abnormalities may overlap with those of monocytic ehrlichiosis ([@bib0020], [@bib0140]). Additionally, doxycycline treatment should be effective against *M. haemocanis* ([@bib0020]). To the authors' knowledge this is the first report of a dog being co-infected with *E. canis*, *H. canis*, *B. vogeli* and *M. haemocanis*.

Dual *E. canis* and *Leishmania* spp. infections, as seen in Case 2, are commonly reported and tend to have prominent clinical signs and slower recoveries compared to dogs with single infections of either pathogen ([@bib0075], [@bib0090]). Since these diseases overlap substantially in their pathology ([@bib0100]), the clinical and clinicopathologic abnormalities seen in this case could have been attributed to either *E. canis* or *Leishmania* spp. infection. In a previous study, dogs that presented with epistaxis, as in Case 2, and with mucosal pallor and pancytopenia, were more likely to be affected by monocytic ehrlichiosis, as opposed to the presence of peripheral lymphadenomegaly, which was more indicative of leishmaniosis ([@bib0100]). Similar to Case 1, the *H. canis* infection in Case 2 was likely to be an incidental finding and most likely of limited clinical significance.

Case 3 was diagnosed with thrombocytotropic anaplasmosis, with thrombocytopenia being the typical clinicopathologic finding of *A. platys* infection. Although a definitive mode of transmission has yet to be demonstrated for *A*. *platys*, *R*. *sanguineus* sensu lato is thought to be the most likely vector ([@bib0135]). Unlike the well-recognised *A. phagocytophilum*-induced immune-mediated polyarthritis ([@bib0135]), *A*. *platys* has not previously been associated with canine arthritis. Therefore the neutrophilic joint inflammation in this case cannot be attributed to *A*. *platys* infection, especially in view of the lack of joint fluid culture or PCR to rule out common pathogens or synovial fluid PCR to amplify *A*. *platys* DNA. Further studies may be warranted to address any potential association of *A*. *platys* and arthritis.

The phylogenetic trees of the sequences derived in this study, together with existing sequences available in Genbank, showed grouping of species derived from a range of countries in different continents, with no differentiation according to geographical origin. For example, the sequences derived from the Cypriot samples did not cluster more closely with those obtained from other countries in Europe than those reported from countries of other continents. In our study short sequences from a single gene were analysed only, and although no differences were revealed, further investigation with additional phylogeny and amplification of multiple and longer genes is needed, in order to prove that these pathogens are not specifically adapted to any particular region.

6. Conclusions {#sec0050}
==============

The current study provides the first molecular documentation for the presence of tick borne pathogens *E. canis*, *A. platys, H. canis*, *B. vogeli* and *M. haemocanis* in dogs in Cyprus. One dog was co-infected with *E. canis*, *H. canis*, *B. vogeli* and *M. haemocanis* and to the best of our knowledge this is the first report of this multiple co-infection in dogs. It further illustrates the widespread distribution of CTBP in Mediterranean countries where *R. sanguineus* sensu lato resides. Veterinarians should consider these pathogens for dogs living in or having travelled to Cyprus. Furthermore, future studies should be carried out to determine the epidemiology of CTBP in Cyprus.
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![Phylogenetic analyses of *Hepatozoon canis* (A), *Babesia vogeli* (B), *Ehrlichia canis* (C), and *Anaplasma platys* (D) gene fragments amplified from cases in this study (as described in [Table 1](#tbl0005){ref-type="table"}) and selected gene fragments available from GenBank, and those of related organisms. Phylogenetic trees were constructed by the maximum likelihood method. The data sets were resampled 1000 times to generate bootstrap percentage values, and values greater than 50% are given at the nodes of the tree.](gr1){#fig0005}

###### 

PCR gene targets, primers used and results for Cases 1--3.

Table 1

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Target genera or species (gene)                           PCR primer sequences                           PCR/Sequencing (length of available sequence data) result and accession numbers                 
  --------------------------------------------------------- ---------------------------------------------- --------------------------------------------------------------------------------- ------------- --------------
  *Babesia/Theileria* spp.\                                 Nbab-F: 5′-AAGCCATGCATGTCTAAGTATAAGCTTTT-3′\   *B. vogeli*\                                                                      Negative      Negative
  (18S rRNA gene) ([@bib0080]; [@bib0110])                  TB-R: 5′-GAATAATTCACCGGATCACTCG-3′             (1432 bp)\                                                                                      
                                                                                                           KU255117                                                                                        

  *Bartonella henselae*\                                    BTHalr1-F: 5′-GAGGGAAATGACTCTCTCAGTAAAAa-3′\   Negative                                                                          Negative      Negative
  (*alr-gcvP* intergenic spacer) ([@bib0130])               BTHalr1-R: 5′-CAGCCAAATATACGGGCTATCCATCAA-3′                                                                                                   

  *Borrelia burgdorferi*\                                   SL-F: 5′-AATAGGTCTAATAATAGCCTTAATAGC −3′\      Negative                                                                          Negative      Negative
  (*ospA* gene) ([@bib0050])                                SL-R: 5′-CTAGTGTTTTGCCATCTTCTTTGAAAA-3′                                                                                                        

  *'Candidatus* Mycoplasma haematoparvum'\                  CMhp-F: 5′-GGAGAATAGCAATCCGAAAGG-3′\           Negative                                                                          Negative      Negative
  (16S rRNA gene) ([@bib0015])                              CMhp-R: 5′-GCATTTACCCCACCAACAAC-3′                                                                                                             

  *Mycoplasma haemocanis*\                                  Mhc-F: 5′-GTGCTACAATGGCGAACACA-3′\             Positive                                                                          Negative      Negative
  (16S rRNA gene) ([@bib0015])                              Mhc-R: 5′-TCCTATCCGAACTGAGACGAA-3′                                                                                                             

  *Ehrlichia canis*\                                        Primary amplification\                         *E. canis*\                                                                       *E. canis*\   Negative
  (16S rRNA gene) ([@bib0045])                              ECC-F: 5′-AGAACGAACGCTGGCGGCAAGCC-3′\          (372 bp)\                                                                         (310 bp)\     
                                                            ECB-R: 5′-CGTATTACCGCGGCTGCTGGCA-3′            KU255118                                                                          KX756971      

                                                            Secondary amplification\                                                                                                                       
                                                            "canis": 5′-CAATTATTTATAGCCTCTGGCTATAGGA-3′\                                                                                                   
                                                            HE3: 5′-TATAGGTACCGTCATTATCTTCCCTAT-3′                                                                                                         

  *Ehrlichia/Anaplasma* spp. (16S rRNA gene) ([@bib0115])   EHR16SD-F: 5′-GGTACCYACAGAAGAAGTCC-3′\         Positive                                                                          Positive      *A. platys*\
                                                            EHR16SR-R: 5′-TAGCACTCATCGTTTACAGC-3′                                                                                                          (222 bp)\
                                                                                                                                                                                                           KU255120

  *Hepatozoon* spp. (18S rRNA gene) ([@bib0055])            Hep-F: 5′-ATACATGAGCAAAATCTCAAC-3′\            *H. canis*\                                                                       *H. canis*\   Negative
                                                            Hep-R: 5′-CTTATTATTCCATGCTGCAG-3′              (515 bp)\                                                                         (624 bp)\     
                                                                                                           KF724626                                                                          KU255116      

  *Leishmania* spp.\                                        LEIT2-F: 5′-CGGCTTCGCACCATGCGGTG-3′\           Negative                                                                          Positive      Negative
  (kDNA) ([@bib0035])                                       LEIB4-R: 5′-ACATCCCTGCCCACATACGC-3′                                                                                                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
